AC Immune SA (ACIU): Next-Year EPS Estimate 160.26%
As of 2026-06-04, AC Immune SA (ACIU) has a next-year EPS growth estimate of 160.26%.
ACIU was first flagged by our screen on 2026-05-27, when analyst consensus for its next-year EPS growth was revised from 159.99% to 160.26%. Current-year growth is projected at 51.25%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 160.26%
- EPS growth this year
- 51.25%
- EPS next quarter (est)
- $0.26
- Last price
- $2.40
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 160.26% | 51.25% | $0.26 | $2.40 |
| 2026-06-03 | 160.26% | 51.49% | $0.26 | $2.39 |
| 2026-06-02 | 160.26% | 51.53% | $0.26 | $2.42 |
| 2026-06-01 | 160.26% | 51.85% | $0.26 | $2.46 |
| 2026-05-31 | 160.26% | 51.71% | $0.26 | $2.66 |
| 2026-05-28 | 160.26% | 51.47% | $0.26 | $2.75 |
| 2026-05-27 | 160.26% | 51.63% | $0.26 | $2.93 |
| 2026-05-26 | 159.99% | 51.53% | $0.26 | $2.93 |
| 2026-05-25 | 159.99% | 51.59% | $0.26 | $2.83 |
| 2026-05-24 | 159.99% | 51.33% | $0.26 | $2.83 |
| 2026-05-21 | 159.99% | 51.29% | $0.26 | $2.85 |
| 2026-05-20 | 159.99% | 51.18% | $0.26 | $2.89 |
| 2026-05-19 | 159.99% | 51.46% | $0.26 | $2.82 |
| 2026-05-18 | 159.99% | 51.28% | $0.26 | $2.77 |
| 2026-05-17 | 159.99% | 51.49% | $0.26 | $2.79 |
| 2026-05-14 | 159.99% | 51.64% | $0.26 | $2.80 |
| 2026-05-13 | 159.99% | 51.71% | $0.26 | $2.77 |
| 2026-05-12 | 159.99% | 51.84% | $0.26 | $2.77 |
| 2026-05-11 | 159.99% | 51.87% | $0.26 | $2.83 |
| 2026-05-10 | 159.99% | 51.69% | $0.26 | $2.86 |
| 2026-05-07 | 159.99% | 51.81% | $0.26 | $2.92 |
| 2026-05-06 | 159.99% | 51.63% | $0.26 | $2.97 |
| 2026-05-05 | 159.99% | 51.47% | $0.26 | $3.01 |
| 2026-05-04 | 159.99% | 51.67% | $0.26 | $3.05 |
| 2026-05-03 | 249.04% | 51.28% | -$0.08 | $2.98 |
| 2026-04-30 | 256.25% | 50.71% | -$0.13 | $3.03 |
| 2026-04-29 | 256.25% | 50.80% | -$0.19 | $2.93 |
| 2026-04-28 | 256.25% | 51.04% | -$0.19 | $3.03 |
| 2026-04-27 | 256.36% | 50.97% | -$0.19 | $2.84 |
| 2026-04-26 | 256.36% | 50.97% | -$0.19 | $2.84 |
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is AC Immune SA's next-year EPS growth estimate?▾
As of 2026-06-04, AC Immune SA (ACIU) has a next-year EPS growth estimate of 160.26%, based on analyst consensus.
When was the latest EPS estimate revision for ACIU?▾
The most recent revision occurred on 2026-05-27, when analysts adjusted the next-year EPS growth estimate from 159.99% to 160.26%.
What sector and industry does AC Immune SA belong to?▾
AC Immune SA operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACIU appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. AC Immune SA (ACIU) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports